Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Angiodynamics (ANGO) Shares Outstanding (Weighted Average) (2016 - 2026)

Angiodynamics' Shares Outstanding (Weighted Average) history spans 17 years, with the latest figure at $41.5 million for Q1 2026.

  • For Q1 2026, Shares Outstanding (Weighted Average) rose 1.61% year-over-year to $41.5 million; the TTM value through Feb 2026 reached $41.5 million, up 1.61%, while the annual FY2025 figure was $40.9 million, 1.67% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $41.5 million in Q1 2026 per ANGO's latest filing, roughly flat from $41.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $41.5 million in Q4 2025 to a low of $39.0 million in Q1 2022.
  • Average Shares Outstanding (Weighted Average) over 5 years is $40.2 million, with a median of $40.2 million recorded in 2024.
  • Peak YoY movement for Shares Outstanding (Weighted Average): increased 1.12% in 2022, then grew 2.04% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $39.5 million in 2022, then rose by 1.85% to $40.2 million in 2023, then rose by 1.75% to $40.9 million in 2024, then rose by 1.52% to $41.5 million in 2025, then decreased by 0.18% to $41.5 million in 2026.
  • Per Business Quant, the three most recent readings for ANGO's Shares Outstanding (Weighted Average) are $41.5 million (Q1 2026), $41.5 million (Q4 2025), and $41.2 million (Q3 2025).